— Know what they know.
Not Investment Advice

ERNA NASDAQ

Ernexa Therapeutics Inc.
1W: -4.7% 1M: +136.1% 3M: +3107.3% YTD: +887.1% 1Y: +240.8% 3Y: -73.1% 5Y: -99.9%
$11.45
-0.80 (-6.53%)
Pre-Market: $11.23 (-0.22, -1.97%)
Weekly Expected Move ±1114.3%
$-290 $-138 $14 $166 $317
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 61 · $3.6M mcap · 99796 float · 1646.97% daily turnover · Short 49% of daily vol
Last Earnings 2026-05-11
EPS
$-6.95
▼ Miss -256.4%
Revenue
Next Earnings 2026-08-17
EPS Estimate
$-2.11
Range: $-2.11 - $-2.11

Estimate vs Actual

Earnings Surprise History

1/18
EPS Beats
0/18
Revenue Beats
6%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-13 annual 2028-12-31 $— $-0.92 ▼ 0.92 $— $—
2026-05-13 quarter 2026-03-31 $-24.00 $-1.95 ▲ 22.05 $— $—
2026-05-13 quarter 2028-09-30 $— $-2.89 ▼ 2.89 $— $—
2026-05-13 annual 2029-12-31 $— $-1.04 ▼ 1.04 $— $—
2026-05-13 quarter 2026-06-30 $-600.00 $-2.11 ▲ 597.89 $— $—
2026-05-13 quarter 2028-03-31 $— $-2.11 ▼ 2.11 $— $—
2026-05-13 quarter 2026-12-31 $-1200.00 $-2.89 ▲ 1197.11 $— $—
2026-05-13 annual 2026-12-31 $-4425.00 $-9.38 ▲ 4415.62 $75,346,000 $75,346,000
2026-05-13 annual 2030-12-31 $— $-1.17 ▼ 1.17 $— $—
2026-05-13 annual 2027-12-31 $— $-1.18 ▼ 1.18 $— $—
2026-05-13 quarter 2027-12-31 $— $-1.95 ▼ 1.95 $— $—
2026-05-13 quarter 2028-06-30 $— $-2.40 ▼ 2.40 $— $—
2026-05-13 quarter 2026-09-30 $-937.50 $-2.40 ▲ 935.10 $— $—
2026-05-05 quarter 2027-03-31 $-39.00 $-975.00 ▼ 936.00 $— $—
2026-05-05 annual 2025-12-31 $-162.00 $-4050.00 ▼ 3888.00 $32,811,999 $32,811,999
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms